Werkgroep Cardiologische centra Nederland English

GALACTIC HF (Includerend)

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction

Middel
omecamtiv mecarbil
Populatie
hartfalen
Fase
III
Jaar aanvang
2016
Meer informatie
ClinicalTrials.gov

Studiedirecteur

dr. J. Schaap (Cardioloog)
Breda, Amphia Ziekenhuis